For a text version of this resume, click here.


Personal Details

Name

Edward Harry Gerstin, Jr.

Home Address

1408 38th Avenue, San Francisco, CA 94122

Business Address

Incyte Genomics, 3160 Porter Drive, Palo Alto, CA 94304 (650) 845-4692

E-mail Address

ed@gerstin.net


History

1999 - present

Senior Scientist/Scientist, IP Bioinformatics, Incyte Genomics, Palo Alto, CA

1997 - 1999

Patent Writer, Legal Department, Incyte Genomics, Palo Alto, CA

1995 - 1997

Post-doctoral Fellow, Ernest Gallo Clinic & Research Center, Department of Neurology University of California, San Francisco

1990 - 1995

Ph.D. in Pharmacology and Toxicology, Department of Pharmacology, College of Medicine University of California, Irvine

1989

B.A. in Biochemistry and Cell Biology, Department of Biology University of California, San Diego


Experiences and Responsibilities

Industry-Related

• Co-lead a team of programmers and bioinformatics associates in the definition, design, development, testing, and production deployment of methods for data analysis, data flow, and data management in the Intellectual Property (IP) department

• Interface with IP department staff to develop innovative methods for high-throughput patent application and prosecution processes

• Act as liaison between IP department and Research, Bioinformatics, and Product Science departments to develop data and methods supporting Legal department functionsMaintain IP Bioinformatics data quality, including gene assemblies, hand-edited full length genes, expression data, genomic data, and annotation data

• Participate in the design, development, and implementation of an Oracle-based sequence tracking database, as well as accompanying user interface

• Wrote numerous patent applications, and provided scientific input for patent prosecution

Academic

• Studied the PKC-dependent regulation of L-type calcium channels by chronic ethanol treatment, in the model neuronal cell line PC12

• Wrote an NIH grant application for postdoctoral funding; funding awarded in 1996

• Characterized muscarinic acetylcholine receptor subtypes in rat peripheral lung by analyzing the pharmacological antagonism of second messenger responses

• Studied the modulation of G-protein coupled receptor signaling pathways in three different tissues using radioligand binding and second messenger assays

Technical Experiences

• Bioinformatics/sequence analysis programs (HMMER, BLAST, BLIMPS, GCG)

• PERL programming, including writing, testing, and implementing numerous PERL scripts

• UNIX, Macintosh and PC environment

• Courses in Relational Database Design, Introductory and Intermediate SQL

• Molecular biology techniques, including RT-PCR, northern analysis, nucleic acid extraction/manipulation, subcloning, and ribonuclease protection assays

• Biochemical analyses of second messenger levels, including cAMP accumulation, adenylate cyclase activity assays, and inositol phosphate accumulation assays, with extensive assay modification/optimization

• Screening agonists using second messenger assays in various tissue preparations

• Cell culture methods


Funding and Awards

1996 - 1997

NIAAA Grant, NRSA Postdoctoral Fellowship

1993 - 1994

Henry Wood Elliott Award, for Outstanding Graduate Student in Pharmacology

1990 - 1992

University of California Regents Fellowship


University Activities

1994

Student Representative, Self Study Task Force of Liaison Committee on Medical Education

1992 - 1994

Vice President - Internal Affairs, Associated Graduate Students


Military Duty

1985 - 1987

Specialist E4, US Army Biomedical Research and Development Laboratory, Fort Detrick, MD


Dissertation

Modulation of Muscarinic Signaling

UMI Dissertation Services, Ann Arbor, MI, 1996

 


Invited Presentations

1997

PKC Isozymes That Mediate Chronic Responses to Ethanol, Annual Meeting of the Research Society on Alcoholism

1995

Toxicology of the Central Nervous System and Eye, in Pharmacological Principles of Toxicology, University of California, Irvine


Publications

For a text version of this resume, click here.